Applicant, as named in the Orange Book

Apil

Next listed expiry: Atelvia on 9 Jan 2028. 2 products with live protection, 2 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Atelvia risedronate sodium	risedronate sodium	022560	9 Jan 2028	patent
Lo Loestrin Fe ethinyl estradiol; norethindrone acetate	ethinyl estradiol; norethindrone acetate	022501	2 Feb 2029	patent, carve-out possible

Products without listed protection (2)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Actonel · 2 strengths risedronate sodium	risedronate sodium	020835	open now	no listed protection
Taytulla ethinyl estradiol; norethindrone acetate	ethinyl estradiol; norethindrone acetate	204426	open now	no listed protection